Stock Movers

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Accenture (ACN) shares are moving after it reported earnings this morning. The company had entered Thursday grappling on how AI will affect the company, with shares down 32.1% year to date.
- Micron Technology (M) shares are moving after it reported fourth-quarter results that beat expectations and gave an outlook that points to durable AI-related demand. Still, Vital Knowledge noted that expectations are very high for the space, “so investors might look at the MU release as not being much better than ‘inline.’”
- Alphabet (GOOG) shares are reacting to the company's announcement of a new frontier model called Gemini 4 Argon, the company announces on their blog. The new model is rolling out with the US government and a set of trusted cyber defenders through its Fairwind Program
- Constellation Energy (CEG) is gaining after the operator of gas power plants said it signed a 20-year power purchase agreement with Amazon, which covers 690 megawatts of nuclear capacity at Maryland’s Calvert Cliffs Clean Energy Center, including a 190-megawatt uprate.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- AG Barr shares fall as much as 4.7% to the lowest level since April 2024 after Berenberg downgraded the maker of the Irn-Bru beverage to hold from buy, seeing subdued volume growth.
- Land Securities Group plans to raise about £500 million ($663 million) through a share sale to fund the acquisition of Metrocentre, one of Britain’s largest shopping malls.
_ Sanofi and Regeneron Pharmaceuticals are expanding their partnership in a deal that could see the US drugmaker receive as much as $8 billion.
See omnystudio.com/listener for privacy information.

Pandora Falls, LandSec Drops, Colruyt Falls
Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Pandora is seeing US demand stabilize at a low level as consumers grapple with inflation and high gas prices, Chief Executive Officer Berta de Pablos-Barbier said.
- Land Securities Group plans to raise about £500 million ($663 million) through a share sale to fund the acquisition of Metrocentre, one of Britain’s largest shopping malls.
- Colruyt drops as much as 11%, the most since May 2025, after the Belgian supermarket operator cut its guidance in a late-Wednesday release summarizing its annual general meeting.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Asian chip-related stocks rise after Micron gave an upbeat forecast for the current quarter, with Japanese chip equipment makers leading gains.
- Gold Fields is considering a sweetened takeover bid for Northern Star Resources according to people familiar with the matter, as the South African miner seeks to overcome resistance to a deal that would create the world’s second-largest gold producer. Shares in Northern Star Resources fall as much as 4.7%.
- South Korean memory names erase early losses to post moderate gains. Samsung rose as much as 2.8%
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers:

- Micron Technology Inc. (MU) shares jumped after the largest US maker of memory chips gave a sales forecast for the current quarter that shattered estimates after the AI building frenzy fueled unprecedented demand.

- Northrop Grumman (NOC) stocks fell after the Pentagon selected the Boeing over rival Northrop Grumman, to build the Navy’s next-generation fighter jet — the Sixth-Generation F/A-XX Strike Fighter, which a JPMorgan analyst called an important win.

- Moderna (MRNA) shares fell the most in a month on Wednesday as a Citigroup Inc. analyst recommended selling the stock, saying its current valuation is “unjustifiable” following an outsized rally. The vaccine maker has been on a tear this year, with most of the stock’s near 600% surge coming off the back of positive data from the firm’s cancer vaccine with Merck & Co. in August.
See omnystudio.com/listener for privacy information.